Moolec Science Sa Stock Net Income
| MLEC Stock | 0.23 0.01 2.27% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Moolec Science's long-term financial health and intrinsic value.
| Last Reported | Projected for Next Year | ||
| Net Loss | -4.1 M | -4.3 M | |
| Net Loss | -6.6 M | -6.9 M | |
| Net Loss | -6.6 M | -6.9 M | |
| Net Loss | (0.22) | (0.23) | |
| Net Income Per E B T | 1.01 | 0.96 |
Moolec | Net Income | Build AI portfolio with Moolec Stock |
Moolec Science SA Company Net Income Analysis
Moolec Science's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Moolec Science Net Income | (7.31 M) |
Most of Moolec Science's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Moolec Science SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Moolec Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Moolec Science is extremely important. It helps to project a fair market value of Moolec Stock properly, considering its historical fundamentals such as Net Income. Since Moolec Science's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Moolec Science's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Moolec Science's interrelated accounts and indicators.
Click cells to compare fundamentals
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Moolec Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Moolec Science SA reported net income of (7.31 Million). This is 102.14% lower than that of the Biotechnology sector and 110.44% lower than that of the Health Care industry. The net income for all United States stocks is 101.28% higher than that of the company.
Moolec Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Moolec Science's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Moolec Science could also be used in its relative valuation, which is a method of valuing Moolec Science by comparing valuation metrics of similar companies.Moolec Science is currently under evaluation in net income category among its peers.
Moolec Fundamentals
| Return On Equity | -1.75 | ||||
| Return On Asset | -0.22 | ||||
| Current Valuation | 22.6 M | ||||
| Shares Outstanding | 10.89 M | ||||
| Shares Owned By Insiders | 28.79 % | ||||
| Shares Owned By Institutions | 0.65 % | ||||
| Number Of Shares Shorted | 36.04 K | ||||
| Price To Book | 0.87 X | ||||
| Price To Sales | 0.11 X | ||||
| Revenue | 5.63 M | ||||
| Gross Profit | (639.5 K) | ||||
| EBITDA | (6.16 M) | ||||
| Net Income | (7.31 M) | ||||
| Total Debt | 14.68 M | ||||
| Book Value Per Share | 0.70 X | ||||
| Cash Flow From Operations | (9.33 M) | ||||
| Short Ratio | 0.27 X | ||||
| Earnings Per Share | (2.10) X | ||||
| Target Price | 3.0 | ||||
| Beta | -0.32 | ||||
| Market Capitalization | 2.45 M | ||||
| Total Asset | 34.79 M | ||||
| Retained Earnings | (65.94 M) | ||||
| Working Capital | 5.6 M | ||||
| Net Asset | 34.79 M |
About Moolec Science Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Moolec Science SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Moolec Science using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Moolec Science SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Moolec Science SA is a strong investment it is important to analyze Moolec Science's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Moolec Science's future performance. For an informed investment choice regarding Moolec Stock, refer to the following important reports:Check out Moolec Science Piotroski F Score and Moolec Science Altman Z Score analysis. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Moolec Science. If investors know Moolec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Moolec Science listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.10) | Revenue Per Share | Quarterly Revenue Growth 9.483 | Return On Assets | Return On Equity |
The market value of Moolec Science SA is measured differently than its book value, which is the value of Moolec that is recorded on the company's balance sheet. Investors also form their own opinion of Moolec Science's value that differs from its market value or its book value, called intrinsic value, which is Moolec Science's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Moolec Science's market value can be influenced by many factors that don't directly affect Moolec Science's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Moolec Science's value and its price as these two are different measures arrived at by different means. Investors typically determine if Moolec Science is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Moolec Science's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.